Patent Assignment
Reel/Frame 066377/0654
Security Interest
Recorded: 2024-01-29
Pages: 16
Assignors
AKEBIA THERAPEUTICS, INC.
Executed: 2024-01-29
KERYX BIOPHARMACEUTICALS, INC.
Executed: 2024-01-29
Assignee
KREOS CAPITAL VII (UK) LIMITED
12 THROGMORTON AVENUE, C/O BLACKROCK INVESTMENT MANAGEMENT (UK) LIMITED - PRIVATE DEBT-EMEA VENTURE & GROWTH LENDING GROUP, LONDON, EC2N 2DL, UNITED KINGDOM
Covered Properties
(57)
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Application:
18/537,481 →
Publication:
US 2024/0358691
Compositions and Methods for Treating Anemia
Process for Preparing [(3-Hydroxypyridine-2-Carbonyl)Amino]Alkanoic Acids, Esters and Amides
Solid Forms of {[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino}Acetic Acid, Compositions, and Uses Thereof
Compositions and Methods for Treating Anemia
Application:
18/500,471 →
Publication:
US 2024/0325361
Therapeutic Methods Using Vadadustat
Application:
18/259,897 →
Publication:
US 2024/0325360
Phd Inhibitor Compounds, Compositions, and Use
Application:
17/906,650 →
Publication:
US 2023/0227426
Phd Inhibitor Compounds, Compositions, and Use
Application:
17/906,652 →
Publication:
US 2023/0159489
Phd Inhibitor Compounds, Compositions, and Their Use
Application:
17/906,653 →
Publication:
US 2023/0212138
Treatment of Viral Infections, of Organ Injury, and of Related Conditions Using a Hif Prolyl Hydroxylase Inhibitor or a Hif-Alpha Stabilizer
Manufacturing Process for 3,5-Dichloropicolinonitrile for Synthesis of Vadadustat
Application:
18/012,012 →
Publication:
US 2023/0286918
Phd Inhibitor Compounds, Compositions, and Methods of Use
Application:
18/041,490 →
Publication:
US 2023/0295110
Modulation of Drug-Drug Interactions of Vadadustat
Application:
18/279,680 →
Publication:
US 2024/0148707
Methods for Treating Viral Infections, Organ Injury, and Related Conditions
Application:
17/974,000 →
Publication:
US 2023/0144457
Method for Producing Nitrogen-Containing Heteroarylcarboxamide Acetic Acid Derivative
Phd Inhibitor Compounds, Compositions, and Methods of Use
Application:
63/612,140 →
Ferric Citrate Dosage Forms
Application:
18/501,536 →
Use of Ferric Citrate in the Treatment of Chronic Kidney Disease Patients
Application:
18/147,240 →
Publication:
US 2024/0041816
Use of Ferric Citrate in the Treatment of and the Reduction of Mortality and Morbidity Related to Adverse Cardiac Events in Chronic Kidney Disease Patients
Application:
18/480,876 →
Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia
Application:
18/069,555 →
Publication:
US 2024/0075006
Pediatric Formulations of Ferric Citrate
Application:
18/517,274 →
Publication:
US 2024/0100011
Modulation of Drug-Drug Interactions of Vadadustat
Application:
18/001,917 →
Publication:
US 2023/0263786
Therapeutic Methods Using Vadadustat
Application:
17/772,856 →
Publication:
US 2023/0285374
Process for Preparing 2-[[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino]Acetic Acid
Prolyl Hydroxylase Inhibitors and Methods of Use
Patent:
47,437 →
Application:
15/875,495 →
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Method of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Process for Preparing 2-[[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino]Acetic Acid
Crystal of Hypoxia Inducible Factor 1 Alpha Prolyl Hydroxylase
Crystal of Hypoxia Inducible Factor 1 Alpha Prolyl Hydroxylase
Crystal of Hypoxia Inducible Factor 1 Alpha Prolyl Hydroxylase
Compositions and Methods for Treating Anemia
Process for Preparing [(3-Hydroxypyridine-2-Carbonyl)Amino]Alkanoic Acids, Esters and Amides
Process for Preparing [(3-Hydroxypyridine-2-Carbonyl)Amino]Alkanoic Acids, Esters and Amides
Process for Preparing [(3-Hydroxypyridine-2-Carbonyl)Amino]Alkanoic Acids, Esters and Amides
Process for Preparing [(3-Hydroxypyridine-2-Carbonyl)Amino]Alkanoic Acids, Esters and Amides
Process for Preparing [(3-Hydroxypyridine-2-Carbonyl)Amino]Alkanoic Acids, Esters and Amides
Solid Forms of {[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino}Acetic Acid, Compositions, and Uses Thereof
Solid Forms of {[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino}Acetic Acid, Compositions, and Uses Thereof
Solid Forms of {[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino}Acetic Acid, Compositions, and Uses Thereof
Solid Forms of {[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino}Acetic Acid, Compositions, and Uses Thereof
Solid Forms of {[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino}Acetic Acid, Compositions, and Uses Thereof
Solid Forms of {[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino}Acetic Acid, Compositions, and Uses Thereof
Solid Forms of 2-(5-(3-Fluorophenyl)-3-Hydroxypicolinamido)Acetic Acid, Compositions, and Uses Thereof
Compositions and Methods for Treating Anemia
Compositions and Methods for Treating Anemia
Solid Forms of {[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino}Acetic Acid
Ferric Citrate Dosage Forms
Ferric Citrate Dosage Forms
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 2, 2022
From: LANTHIER, CHRISTOPHER M.; GORIN, BORIS; OUDENES, JAN; DIXON, CRAIG EDWARD
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 058868/0265 →
Assignment of Assignor's Interest
Jun 13, 2022
From: FUKUHARA, KOHKI; KISHIDA, MUNEKI; MORODA, ATSUSHI; OOTSUKI, KAZUFUMI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 060182/0597 →
Assignment of Assignor's Interest
Jun 14, 2022
From: DEGOMA, EMIL
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 060195/0916 →
Assignment of Assignor's Interest
Jun 14, 2022
From: KANEKO, GENKI; MARUYAMA, NOBUKO
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 060196/0114 →
Assignment of Assignor's Interest
Jul 28, 2022
From: THE PROCTOR & GAMBLE COMPANY
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 061002/0212 →
Assignment of Assignor's Interest
Jul 28, 2022
From: WARNER CHILCOTT COMPANY, LLC
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 060660/0687 →
Assignment of Assignor's Interest
Jul 28, 2022
From: WU, SHENGDE; WARSHAKOON, NAMAL C.; EVDOKIMOV, ARTEM G.; GREIS, KENNETH D.
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 060660/0322 →
Assignment of Assignor's Interest
Jul 28, 2022
From: KAWAMOTO, RICHARD MASARU
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 060660/0191 →
Assignment of Assignor's Interest
Jul 29, 2022
From: MITSUBISHI TANABE PHARMA CORPORATION
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 060674/0065 →
Assignment of Assignor's Interest
Sep 30, 2022
From: FLEMING, PAUL E.; BLAISDELL, THOMAS P.; ALLU, SENKARA RAO
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 061267/0186 →
Assignment of Assignor's Interest
Sep 30, 2022
From: FLEMING, PAUL E.; BLAISDELL, THOMAS P.; ALLU, SENKARA RAO
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 061264/0927 →
Assignment of Assignor's Interest
Sep 30, 2022
From: FLEMING, PAUL E.; BLAISDELL, THOMAS P.; ALLU, SENKARA RAO
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 061266/0818 →
Assignment of Assignor's Interest
Dec 27, 2022
From: BURKE, STEVEN; RABINOWITZ, MICHAEL
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 062212/0302 →
Assignment of Assignor's Interest
Jan 26, 2023
From: BURKE, STEVEN; RABINOWITZ, MICHAEL
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 062493/0789 →
Assignment of Assignor's Interest
Jan 31, 2023
From: CHAVAN, AJIT; SAWANT, RISHIKESH
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 062543/0466 →
Assignment of Assignor's Interest
Jan 31, 2023
From: KOKADO, YOSHIMASA; NANJO, TAKEHIRO; KINOSHITA, SHUJI; KONISHI, NAOMI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 062543/0448 →
Assignment of Assignor's Interest
Feb 13, 2023
From: PORADOSU, ENRIQUE; OLIVIERO, III, JAMES F.; BENTSUR, RON
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 062672/0612 →
Thirteenth Amended and Restated Intellectual Property Security Agreement
Mar 29, 2023
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063189/0065 →
Assignment of Assignor's Interest
Jun 6, 2023
From: COPP, JAMES DENSMORE; NEWMAN, ANN W.; LUONG, ANNE
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 063861/0223 →
Assignment of Assignor's Interest
Jun 9, 2023
From: BLAISDELL, THOMAS P.; ALLU, SENKARA RAO; FLEMING, PAUL E.
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 063912/0548 →
Assignment of Assignor's Interest
Jun 30, 2023
From: BURKE, STEVEN; CHAVAN, AJIT; KHAWAJA, ZEESHAN
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 064129/0736 →
Assignment of Assignor's Interest
Sep 20, 2023
From: CHAVAN, AJIT; BURKE, STEVEN
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 064967/0244 →
Assignment of Assignor's Interest
Sep 20, 2023
From: PORADOSU, ENRIQUE; BENTSUR, RON; SHEMESH, SHAY DAVID
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 064963/0220 →
Assignment of Assignor's Interest
Oct 6, 2023
From: PORADOSU, ENRIQUE; OLIVIERO, JAMES F., III; BENTSUR, RON
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 065147/0549 →
Assignment of Assignor's Interest
Nov 6, 2023
From: CHANDORKAR, GURUDATT AJAY
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 065469/0854 →